Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,332,000 | 1,036,000 | 1,898,000 | 1,295,000 | 1,176,000 |
| Marketable Securities | 8,561,000 | 7,579,000 | 7,565,000 | 7,721,000 | 6,633,000 |
| Receivables | 6,453,000 | 4,798,000 | 5,679,000 | 5,435,000 | 5,773,000 |
| Inventories | 2,750,000 | 2,485,000 | 2,842,000 | 2,926,000 | 2,889,000 |
| Other current assets | 250,000 | 1,896,000 | 241,000 | 285,000 | 138,000 |
| TOTAL | $20,970,000 | $19,212,000 | $19,999,000 | $19,598,000 | $18,698,000 |
| Non-Current Assets | |||||
| PPE Net | 10,496,000 | 9,783,000 | 10,166,000 | 9,818,000 | 9,601,000 |
| Investments And Advances | 5,304,000 | 5,724,000 | 4,258,000 | 3,218,000 | 2,373,000 |
| Intangibles | 1,824,000 | 1,689,000 | 1,764,000 | 1,776,000 | 1,797,000 |
| Other Non-Current Assets | 2,722,000 | 2,745,000 | 2,619,000 | 2,531,000 | 2,677,000 |
| TOTAL | $20,346,000 | $19,941,000 | $18,807,000 | $17,343,000 | $16,448,000 |
| Total Assets | $41,316,000 | $39,153,000 | $38,806,000 | $36,941,000 | $35,146,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,746,000 | 6,263,000 | 6,362,000 | 4,638,000 | 3,963,000 |
| Accounts payable and accrued liabilities | 1,591,000 | 1,411,000 | 1,632,000 | 1,542,000 | 1,418,000 |
| Accrued Expenses | 915,000 | 1,026,000 | 1,010,000 | 965,000 | 928,000 |
| Other current liabilities | 3,102,000 | 2,866,000 | 3,115,000 | 3,113,000 | 3,508,000 |
| TOTAL | $14,729,000 | $13,729,000 | $13,039,000 | $11,984,000 | $10,874,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,580,000 | 2,609,000 | 2,087,000 | 2,367,000 | 1,888,000 |
| Other Non-Current Liabilities | 3,957,000 | 4,124,000 | 4,351,000 | 4,139,000 | 4,034,000 |
| TOTAL | $6,913,000 | $7,131,000 | $6,871,000 | $7,141,000 | $6,524,000 |
| Total Liabilities | $21,642,000 | $20,860,000 | $19,910,000 | $19,125,000 | $17,398,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,244,712 | 6,265,231 | 6,286,722 | 6,312,711 | 6,312,851 |
| Common Shares | 340,000 | 340,000 | 339,000 | 338,000 | 338,000 |
| Retained earnings | 26,788,000 | 24,430,000 | 23,967,000 | 21,899,000 | 21,444,000 |
| Other shareholders' equity | -4,204,000 | -4,399,000 | -4,368,000 | -4,369,000 | -4,196,000 |
| TOTAL | $19,674,000 | $18,293,000 | $18,896,000 | $17,816,000 | $17,748,000 |
| Total Liabilities And Equity | $41,316,000 | $39,153,000 | $38,806,000 | $36,941,000 | $35,146,000 |